💊✨😊ZURZUVAE® (Zuranolone): A New 2-Week Oral Treatment for Depression Launching in March 2026
A Novel GABA-Based Approach to Major Depressive Disorder (MDD) In March 2026, ZURZUVAE® (zuranolone) will become available as a novel oral treatment option for major depressive disorder (MDD) and depressive states. What makes this medica...